Table 1 Participants Study Cohort Characteristics
Characteristics | Dysfunction Group (n = 24) | Non- Dysfunction Group (n = 11) | P |
|---|---|---|---|
Age, months (mean ± SD) | 20.9 ± 12.4 | 15.6 ± 12.9 | 0.005 |
Male sex (%) | 58.3 (14/24) | 63.6 (7/11) | 0.766 |
Reason for admission (%) | |||
 Cardiovascular | 8.3 (2/24) | 9.1 (1/11) | 0.941 |
 Respiratory | 83.3 (20/24) | 81.8 (9/11) | 0.912 |
 Gastrointestinal | 8.3 (2/24) | 9.1 (1/11) | 0.941 |
PCIS (mean ± SD) | 81.08 ± 9.09 | 92.18 ± 5.17 | 0.001 |
PICU length of stay, d, median (IQR) | 22.50 (14.50–27.75) | 9.00 (7.00–17.00) | 0.029 |
Use of vasoactive medications, n (%) | 58.2 (14/24) | 8.2 (9/11) | 0.006 |
IMV days (mean ± SD) | 7.46 ± 5.34 | 1.27 ± 2.83 | 0.001 |
Sedative days, d, median (IQR) | 8.50 (2.50–13.75) | 2.0 (1.0–7.0) | 0.021 |
Methylprednisolone, d, median (IQR) | 5.5 (4.25–7.75) | 3.00 (0.00–7.00) | 0.130 |
CRRT days, d, median (IQR) | 3.50 (0.00–7.00) |  |  |
Sepsis (%) | 20.8 (5/24) | 9.1 (1/11) | < 0.001 |
Surgical, n (%) | 8.3 (2/24) | Â | Â |